Gf Fund Management Co. Ltd. Intellia Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.97 Trillion
- Q2 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,608 shares of NTLA stock, worth $53,307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,608
Previous 2,608
-0.0%
Holding current value
$53,307
Previous $18.5 Million
31.93%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
333Shares Held
97.2MCall Options Held
1.66MPut Options Held
1.03M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$266 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$222 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$196 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.12MShares$84.1 Million0.0% of portfolio
-
State Street Corp Boston, MA4.04MShares$82.6 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.55B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...